Yamamoto et al., suggested that ACE1 I/D polymorphism could be a potential genetic marker for COVID-19 infectivity and may be involved in the various diseases caused by the virus, including the cytokine storm, pneumonia, thrombosis, DIC, ischemic stroke and renal injury [47]. The gene discussed is ACE; the disease is susceptibility to pneumonia measurement.